ClinicalTrials.gg
Sign In

Hemangiopericytoma, Malignant clinical trials

The registry lists 26 studies for Hemangiopericytoma, Malignant across more than 10 countries. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2023-08-04.

Status

Completed
21
Status unknown
3
Terminated
2

Phase

Phase 2
15
Phase 3
8
Phase 1
4

Where

United States
11
United Kingdom
10
Belgium
7
Denmark
7
France
7
Germany
6

Who runs them

European Organisation for Research and Treatment of Cancer - EORTC (9) · National Cancer Institute (NCI) (4) · Societe Internationale d'Oncologie Pediatrique (2) · City of Hope Medical Center (1) · NCIC Clinical Trials Group (1) · Herbert Irving Comprehensive Cancer Center (1) · University of Miami (1) · The Christie NHS Foundation Trust (1)

What is being tested here

Drugs under test in Hemangiopericytoma, Malignant studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ifosfamide045
Doxorubicin044
Trabectedin012
Perifosine001
Vatalanib001
Romidepsin001
Celecoxib001
Cixutumumab001
Sunitinib001
Sorafenib001

Drug classes tested here Alkylating agents 6 · Tyrosine kinase inhibitors (TKIs) 4

Who these studies take

No Hemangiopericytoma, Malignant study is recruiting now.

Across all 26 studies, recruiting or not: 31% stop at 75 or younger and 19% at 65; 54% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 26 of 26. search them.